703 related articles for article (PubMed ID: 12377814)
21. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.
Beutler E; Felitti V; Gelbart T; Ho N
Ann Intern Med; 2000 Sep; 133(5):329-37. PubMed ID: 10979877
[TBL] [Abstract][Full Text] [Related]
22. HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors.
Arya N; Chakrabrati S; Hegele RA; Adams PC
Blood Cells Mol Dis; 1999; 25(5-6):354-7. PubMed ID: 10660483
[TBL] [Abstract][Full Text] [Related]
23. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
[TBL] [Abstract][Full Text] [Related]
24. Hfe mutations and iron overload in patients with alcoholic liver disease.
Costa-Matos L; Batista P; Monteiro N; Henriques P; Girão F; Carvalho A
Arq Gastroenterol; 2013; 50(1):35-41. PubMed ID: 23657305
[TBL] [Abstract][Full Text] [Related]
25. Analysis of HFE gene mutations and HLA-A alleles in Brazilian patients with iron overload.
Cançado RD; Guglielmi AC; Vergueiro CS; Rolim EG; Figueiredo MS; Chiattone CS
Sao Paulo Med J; 2006 Mar; 124(2):55-60. PubMed ID: 16878186
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance-associated hepatic iron overload.
Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y
Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879
[TBL] [Abstract][Full Text] [Related]
27. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
[TBL] [Abstract][Full Text] [Related]
28. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.
Cukjati M; Vaupotic T; Rupreht R; Curin-Serbec V
BMC Med Genet; 2007 Nov; 8():69. PubMed ID: 18036208
[TBL] [Abstract][Full Text] [Related]
30. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
Pedersen P; Milman N
Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
[TBL] [Abstract][Full Text] [Related]
31. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
[TBL] [Abstract][Full Text] [Related]
32. The role of HFE mutations on iron metabolism in beta-thalassemia carriers.
Martins R; Picanço I; Fonseca A; Ferreira L; Rodrigues O; Coelho M; Seixas T; Miranda A; Nunes B; Costa L; Romão L; Faustino P
J Hum Genet; 2004; 49(12):651-655. PubMed ID: 15538648
[TBL] [Abstract][Full Text] [Related]
33. Significance of H63D homozygosity in a Basque population with hemochromatosis.
Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
[TBL] [Abstract][Full Text] [Related]
34. Screening for iron overload in the Turkish population.
Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
[TBL] [Abstract][Full Text] [Related]
35. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
[TBL] [Abstract][Full Text] [Related]
36. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK
Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
[TBL] [Abstract][Full Text] [Related]
37. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives.
Moirand R; Jouanolle AM; Brissot P; Le Gall JY; David V; Deugnier Y
Gastroenterology; 1999 Feb; 116(2):372-7. PubMed ID: 9922318
[TBL] [Abstract][Full Text] [Related]
39. HFE gene C282Y, H63D and S65C mutations frequency in the Transylvania region, Romania.
Trifa AP; Popp RA; Militaru MS; Farcaş MF; Crişan TO; Gana I; Cucuianu A; Pop IV
J Gastrointestin Liver Dis; 2012 Jun; 21(2):177-80. PubMed ID: 22720307
[TBL] [Abstract][Full Text] [Related]
40. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]